Holen Sie sich die Stockscreener-App
5.01
3.73%
0.18
Handel nachbörslich:
5.01
Schlusskurs vom Vortag:
$4.83
Offen:
$4.87
24-Stunden-Volumen:
760.30K
Relative Volume:
1.04
Marktkapitalisierung:
$342.79M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-96.66M
KGV:
-2.3302
EPS:
-2.15
Netto-Cashflow:
$-83.73M
1W Leistung:
+10.35%
1M Leistung:
+8.44%
6M Leistung:
-19.32%
1J Leistung:
-67.02%
1-Tages-Spanne:
$4.72
$5.035
1-Wochen-Bereich:
$4.49
$5.035
52-Wochen-Spanne:
$2.86
$16.62
Olema Pharmaceuticals Inc Stock (OLMA) Company Profile
Firmenname
Olema Pharmaceuticals Inc
Sektor
Branche
Telefon
(415) 651-3316
Adresse
780 BRANNAN STREET, SAN FRANCISCO
Vergleichen Sie OLMA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OLMA
Olema Pharmaceuticals Inc
|
5.01 | 322.26M | 0 | -96.66M | -83.73M | -2.15 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.41 | 120.60B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.14 | 60.80B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
330.55 | 42.87B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
598.79 | 36.23B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
305.74 | 31.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Olema Pharmaceuticals Inc Stock (OLMA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-04-02 | Eingeleitet | Goldman | Buy |
| 2024-01-30 | Eingeleitet | Citigroup | Buy |
| 2023-07-21 | Eingeleitet | Oppenheimer | Outperform |
| 2023-05-05 | Eingeleitet | CapitalOne | Overweight |
| 2023-02-22 | Eingeleitet | Credit Suisse | Outperform |
| 2022-07-06 | Fortgesetzt | Canaccord Genuity | Buy |
| 2022-06-09 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2022-02-28 | Eingeleitet | H.C. Wainwright | Neutral |
| 2021-12-07 | Fortgesetzt | Cowen | Outperform |
| 2020-12-14 | Eingeleitet | Canaccord Genuity | Buy |
| 2020-12-14 | Eingeleitet | Cowen | Outperform |
| 2020-12-14 | Eingeleitet | JP Morgan | Overweight |
| 2020-12-14 | Eingeleitet | Jefferies | Buy |
Alle ansehen
Olema Pharmaceuticals Inc Aktie (OLMA) Neueste Nachrichten
Advanced analytics toolkit walkthrough for Olema Pharmaceuticals Inc.Swing Entry Risk Mitigation with Chart Analysis - Newser
Olema Pharmaceuticals (OLMA) Expected to Announce Earnings on Tuesday - MarketBeat
Using fundamentals and technicals on Olema Pharmaceuticals Inc.Daily Stock Watch Summary with Key Insights - Newser
Can a trend reversal in Olema Pharmaceuticals Inc. lead to recoveryFree Fast Gaining Stock Screener Report - Newser
Olema Pharmaceuticals Inc. stock trend forecastDaily Exit and Entry Price Prediction - Newser
What makes Olema Pharmaceuticals Inc. stock price move sharplyShort-Term Bounce Forecast for Oversold Stocks - Newser
How does Olema Pharmaceuticals Inc. compare to its industry peersEarnings Report Alerts For Every Investor - jammulinksnews.com
Does Olema Pharmaceuticals Inc. stock perform well during market downturnsSkyrocketing returns - jammulinksnews.com
What is the risk reward ratio of investing in Olema Pharmaceuticals Inc. stockEarnings Report Strategy With High Returns - jammulinksnews.com
Combining price and volume data for Olema Pharmaceuticals Inc.Free Stock Market Watch With Alerts - Newser
Is a relief rally coming for Olema Pharmaceuticals Inc. holdersFree Verified Signal From Chart Patterns - Newser
Olema Pharmaceuticals Inc. stock trend forecast Free High Return Stock Focus With Safety - Newser
Is a relief rally coming for Olema Pharmaceuticals Inc. holders Risk Shielded Trade Watch with Analysis - Newser
Is a relief rally coming for Olema Pharmaceuticals Inc. holders Free Stock Screener With Smart Filters - metal.it
What catalysts could drive Olema Pharmaceuticals Inc. stock higher in 2025Unlock powerful trading strategies for gains - jammulinksnews.com
What are Olema Pharmaceuticals Inc. company’s key revenue driversBuild a diversified portfolio for steady growth - jammulinksnews.com
What are the latest earnings results for Olema Pharmaceuticals Inc.Maximize gains with strategic stock entries - jammulinksnews.com
Olema Pharmaceuticals Inc. Stock Support and Resistance Levels You Should KnowFree Stock Trading Signals - Newser
How Interest Rate Changes Impact Olema Pharmaceuticals Inc. Stock PerformanceProven Trading Plan - Newser
Is Olema Pharmaceuticals Inc. a good long term investmentFree Investment Case Studies - PrintWeekIndia
What analysts say about Olema Pharmaceuticals Inc. stockConsistently outstanding ROI - Autocar Professional
Olema Pharmaceuticals Inc. Stock Analysis and ForecastSuperior risk-adjusted returns - jammulinksnews.com
What drives Olema Pharmaceuticals Inc. stock priceConsistently high yield - jammulinksnews.com
Why Olema Pharmaceuticals Inc. stock attracts strong analyst attentionFree Access to Group - Newser
How Olema Pharmaceuticals Inc. stock performs during market volatilityFree Top Growth Stock Recommendations - Newser
Finanzdaten der Olema Pharmaceuticals Inc-Aktie (OLMA)
Umsatz
Nettogewinn
Free Cashflow
ENV
10.28%
2.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):